Plantar fascial fibromatosis. Plantar fascial fibromatosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: People with a clinical diagnosis of chronic plantar fasciitis who have received supportive treatment for at least 2 months and have not responded to the treatment Presence of pain in the heel for at least two months with a VAS between numbers 3 and 7 (out of 10) at the time of examination
Exclusion criteria
Exclusion criteria: Suffering from a significant physical and mental illness that increases the risk of disrupting the study process Drug or Substance addiction Pregnancy or breastfeeding The presence of injury in the studied lower limb A history of Corticosteroid or PRP injection in the plantar fascia during at least the last 6 months History of Neuromuscular diseases such as Myasthenia gravis Allergy to botulinum toxin or eggs Suffering from orthopedic and medical problems that are contrary to the possibility of the person's participation in the study Heel pain with diagnoses other than plantar fasciitis The use of foot Orthoses since the time of entering the study Use of NSAID with anti-inflammatory dose during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tenderness using VAS (Visual Analog Scale). Timepoint: Before injection and after eight weeks. Method of measurement: A 10-mm line will be drawn on paper, marked with '0' at one end and '10' at the other. Participants will be asked to indicate their overall pain level by marking a point on the line.;FAAM questionnaire. Timepoint: Before injection and after eight weeks. Method of measurement: Responses to the questionnaire and the total scores of the daily activities and sports subscales will be recorded. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences